Home
    Disclaimer

    Esketamine Well-documented
    Well-documented
    Multiple authoritative sources agree on dosing and effects.
    • 2 corroborating sources
    • 3 ROAs with full dose ladders
    • duration data present
    • 18 combo interactions documented
    • PubChem toxicity data
    • dose data not in PW/TripSit (unverifiable)

    Aliases: Spravato, Ketanest, Ketanest s

    Summary TheDrug.Wiki PsychonautWiki

    Ketamine (also known as Ket, K, Special K, vitamin K, Kitty, and others) is a classical dissociative substance of the arylcyclohexylamine class. It is perhaps the best-known and archetypal member of the dissociatives, a diverse group which includes PCP, methoxetamine, DXM, and nitrous oxide. The mechanism of action is not fully known, although blocking of the NMDA glutamate receptor is thought to be involved.

    Dose Information TheDrug.Wiki

    No curated dose ladder is available for this substance. The figures below are drawn from SubstanceIndex (DoseWiki) as a fallback — often a conservative threshold only. Treat them as approximate and cross-reference before use.

    ROA Light Common Strong Heavy
    Insufflated 28-56mg 56-84mg 84mg+ -
    Intramuscular 0.15-0.3mg/kg 0.3-0.5mg/kg 0.5-0.75mg/kg 0.75-1mg/kg+
    Intravenous 0.1-0.25mg/kg 0.25-0.5mg/kg 0.5-0.8mg/kg 0.8-1mg/kg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki

    ROA Peak Offset After Effects Total
    Insufflated 20-60 min 1-2 hrs 2-24 hrs 1-2 hrs
    Intramuscular 20-60 min 1-2 hrs 2-24 hrs 1-2 hrs
    Intravenous 20-60 min 1-2 hrs 2-24 hrs 1-2 hrs

    Effect Profile

    2 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Dissociative 6.6
    Strong+ 7/10

    Strong dissociative depth and motor impairment with mild mania and insight

    Dissociative Depth ×3
    10
    depersonalization derealization physical disconnection cognitive disconnection visual disconnection spatial disorientation +1 more
    Mania / Compulsion ×1
    4
    disinhibition stimulation
    Insight / Novel Thought ×2
    4
    conceptual thinking immersion enhancement
    Motor / Sensory Impairment ×1
    8
    motor control loss physical disconnection spatial disorientation visual disconnection

    Tolerance

    Build-up develops with repeated use over days to weeks
    Reset 2–4 weeks for noticeable reduction

    Tolerance Decay

    Full tolerance 1d Half tolerance 14d Baseline ~28d

    Rapid tolerance to subjective dissociation is commonly reported with repeated (daily or multi‑day) use and often partially decays over several days to weeks; estimates above are heuristic and based on community/HR summaries rather than controlled PK/PD studies.

    Effects TheDrug.Wiki

    Positive
    • Pain relief
    • Analgesia
    • Stimulation
    Negative
    • Increased blood pressure
    • Nausea
    • Vertigo
    • Insomnia
    • Headache
    Neutral
    • Sedation
    • Physical disconnection
    Positive
    • Cognitive euphoria
    • Conceptual thinking
    • Immersion enhancement
    • Depression reduction
    Negative
    • Depersonalization
    • Derealization
    • Motor control loss
    • Memory suppression
    • Cognitive disconnection
    • Dizziness
    • Anxiety
    Neutral
    • Dissociation
    • Time distortion
    Positive
    • Physical enhancement
    Negative
    • Spatial disorientation
    • Derealization
    • Light sensitivity
    • Disinhibition
    • Appetite suppression
    Neutral
    • Visual distortions
    • Visual disconnection
    • Dulled perception
    • Metallic taste

    Combinations TripSit

    Cross-Check Esketamine with another substance

    Helpful Links